Clinical trial · Observational
Tracking Physical Activity Throughout Chemotherapy for Breast Cancer
NCT03041545CI-TRIAL-00033287completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Physical activity during chemotherapy has been shown to increase patient health and wellbeing as well as improve outcomes in breast cancer patients. The primary aim of this project is to determine the feasibility of incorporating wearable sensors into clinical care by having breast cancer patients, undergoing chemotherapy, wear a commercially available monitor (Fitbit) that tracks physical activity, sleep, and heart rate monitor.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Physical Activity | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fitbit | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Fitbit
- description
- All participants will be asked to wear the Fitbit as much as possible and to sync it at least once a week, from one week prior to start of chemotherapy treatment to six months after ending chemotherapy.
- interventionNames
- Device: Fitbit
Primary outcomes (1)
- measure
- Recruitment
- timeFrame
- 06/01/2015-06/01/2018
- description
- Enrolling \>20% of eligible patients
Secondary outcomes (1)
- measure
- Retention
- timeFrame
- From date enrolled into the study until 1 week after the date of the last infusion center visit for chemotherapy, which is typically up to 6 months.
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Female * Diagnosed with breast cancer * Scheduled to receive chemotherapy, but has not yet started chemotherapy * Receiving chemotherapy at a University of California, San Diego clinic * Willingness to wear the Fitbit throughout the course of chemotherapy * Access to a computer or Bluetooth enabled phone to sync Fitbit data * Able to read and communicate in English Exclusion Criteria: • Serious physical limitation that greatly limits mobility
References
Publications (0)
Data not yet available
No reference posted for this study.